发明名称 |
Use of lactulose in the treatment of autism |
摘要 |
A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity. |
申请公布号 |
US9345721(B2) |
申请公布日期 |
2016.05.24 |
申请号 |
US201314087930 |
申请日期 |
2013.11.22 |
申请人 |
Curemark, LLC |
发明人 |
Fallon Joan M.;Feltenstein Richard |
分类号 |
A61K31/7016;A61K35/37;A61K31/045;A61K31/7012 |
主分类号 |
A61K31/7016 |
代理机构 |
Wilson Sonsini Goodrich & Rosati |
代理人 |
Wilson Sonsini Goodrich & Rosati |
主权项 |
1. A method for treating an individual diagnosed with an autistic disorder, the method comprising administering a therapeutically effective amount of lactulose and mannitol to the individual, wherein administration of the lactulose follows administration of an antibiotic, and wherein administration of lactulose increases the number of lactobacilli and bifidobacteria in a gut flora. |
地址 |
Rye NY US |